ArticleCancer medicine2021
MLL3 is a de novo cause of endocrine therapy resistance.
Kimberly M Stauffer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleCancer medicine2021
Kimberly M Stauffer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.